SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BRANCHINI, Alessio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.489
EU - Europa 2.517
AS - Asia 1.927
SA - Sud America 84
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 10.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.442
IT - Italia 1.231
SG - Singapore 850
CN - Cina 631
DE - Germania 293
PL - Polonia 255
UA - Ucraina 210
TR - Turchia 164
GB - Regno Unito 129
FI - Finlandia 106
ID - Indonesia 98
SE - Svezia 84
BR - Brasile 69
NL - Olanda 42
CA - Canada 40
IN - India 39
HK - Hong Kong 37
BE - Belgio 31
CZ - Repubblica Ceca 26
FR - Francia 25
VN - Vietnam 25
IR - Iran 16
RO - Romania 15
DK - Danimarca 14
JP - Giappone 12
NO - Norvegia 12
EU - Europa 10
IQ - Iraq 10
TW - Taiwan 10
AU - Australia 7
RU - Federazione Russa 7
KR - Corea 6
PK - Pakistan 6
CH - Svizzera 5
IE - Irlanda 5
LT - Lituania 5
PT - Portogallo 5
AR - Argentina 4
AT - Austria 4
CO - Colombia 4
GE - Georgia 4
ZA - Sudafrica 4
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
MX - Messico 3
NG - Nigeria 3
UZ - Uzbekistan 3
CL - Cile 2
EC - Ecuador 2
ES - Italia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
PA - Panama 2
PH - Filippine 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 10.054
Salva come PNG Salva come JPEG
Città #
Chandler 570
Fairfield 504
Santa Clara 442
Woodbridge 441
Singapore 400
Ferrara 331
Ashburn 281
Ann Arbor 277
Houston 264
Warsaw 254
Wilmington 220
Jacksonville 215
Seattle 206
Cambridge 173
New York 126
Izmir 119
Princeton 118
Nanjing 101
Milan 98
Jakarta 91
Shanghai 90
Dearborn 88
Beijing 74
Bremen 62
Helsinki 61
Boardman 59
Los Angeles 48
San Diego 45
Rome 42
Redwood City 41
The Dalles 37
Nanchang 36
Falls Church 35
Bologna 34
Shenyang 32
Toronto 29
Florence 27
Brussels 25
Falkenstein 25
Hong Kong 24
Dong Ket 23
London 23
Guangzhou 22
Hebei 21
Jiaxing 21
Auburn Hills 20
San Mateo 20
Brno 17
Jinan 17
Kunming 16
Changsha 15
Norwalk 15
Nuremberg 14
Tianjin 14
Frankfurt am Main 13
Zhengzhou 13
Hangzhou 12
Washington 12
Mountain View 11
Ningbo 11
Munich 10
Praia A Mare 10
Hefei 9
Monmouth Junction 9
Naples 9
Piemonte 9
Verona 9
Augusta 8
Council Bluffs 8
Des Moines 8
Duncan 8
Ferrara di Monte Baldo 8
Mānsa 8
Oslo 8
São Paulo 8
Baghdad 7
Bari 7
Fairford 7
Hounslow 7
Andover 6
Arona 6
Chicago 6
Leawood 6
Orange 6
Ottawa 6
Padova 6
Redmond 6
Albissola Marina 5
Catania 5
Fuzhou 5
Haikou 5
Lappeenranta 5
Lauterbourg 5
Modena 5
Olomouc 5
Philadelphia 5
Rochester 5
Taipei 5
Addison 4
Amsterdam 4
Totale 6.743
Salva come PNG Salva come JPEG
Nome #
La sanificazione delle degenze ospedaliere: nuove strategie per la riduzione delle infezioni correlate all’assistenza sanitaria 319
La sanificazione delle degenze ospedaliere: nuove strategie a supporto della riduzione delle infezioni correlate all’assistenza sanitaria 303
Impact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome Remodulation 233
The carboxyl-terminal region of coagulation factors: role in biosynthesis and function of FVII and FX 207
Il sistema di sanificazione PCHS Probiotic Cleaning Hygien System: risultati delle indagini sperimentali in vitro e in campo 202
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 185
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 180
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 169
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth 167
PCHS (Probiotic Hygiene Cleaning System) Protocol: reduction of hospital environmental impact with a new and innovative technology for cleaning in Ferrara University Hospital 163
Hard surface biocontrol in hospitals using microbial-based cleaning products 158
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 152
Chronic sleep deprivation markedly reduces coagulation factor VII expression 147
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 143
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 142
Reduction of the microbial load on hospital surfaces through probiotic-based cleaning procedures: a new strategy to control nosocomial infections 136
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 134
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 133
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 131
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 129
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 129
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 127
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 123
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 122
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 119
I probiotici: aspetti generali e valutazioni sulla sicurezza d’impiego 118
Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 114
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 113
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 111
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 111
Disease-causing variants of the conserved+2T of 5 ' splice sites can be rescued by engineered U1snRNAs 110
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 110
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 109
F9 genotype and PK hemophilia B international study (GEPKHIS) 108
Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity 105
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 103
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 100
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 96
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 95
Activated factor VII: antithrombin complex plasma concentration in subjects with or without angiographically demonstrated coronary artery disease and myocardial infarction 94
null 94
null 93
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 89
Improved intracellular processing of protein variants as a personalized therapeutic approach for Haemophilia 88
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype 87
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants 86
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 85
null 84
An optimized in vitro expression platform identifies Haemophilia B nonsense mutations, and thus patients, eligible for therapeutic drug-induced readthrough 83
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 82
Molecular mechanisms and determinants of innovative correction approaches in coagulation factor deficiencies 80
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 79
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 73
null 73
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 73
null 71
Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity 71
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia 71
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 69
A recoded view on the F9 p.Cys178Ter pathogenic mechanism 69
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 69
The carboxyl-terminal region of coagulation serine proteases: A matter of cut and change 68
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics 68
The FVII R402X nonsense mutation, associated with an asymptomatic phenotype, is responsible for small amounts of circulating protein with improved coagulant activity 68
Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates 67
MOLECULAR MECHANISMS AND THERAPEUTIC APROACHES FOR RESTORATION OF mRNA TRANSCRIPTION, MATURATION AND TRANSLATION IN INHERITED COAGULATION FACTOR DEFICIENCIES 66
Hemostasis gene expression of the internal jugular and saphenous veins 65
Rational engineering of a novel factor IX albumin fusion protein results in enhanced coagulant activity and pharmacokinetic profile 64
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity 64
Exploring spontaneous readthrough over recurrent F8 nonsense mutations: potential correlation with inhibitor risk? 64
Effects of Partial Chronic Sleep Deprivation on the Mouse Blood Coagulation Cascade. 64
Molecular insights into determinants of translational readthrough and implications for nonsense suppression approaches 63
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 62
Identification of novel mechanisms underlying functional response to drug-induced readthrough of haemophilia B nonsense mutations 62
Design of a novel factor IX albumin fusion protein with enhanced coagulant activity and pharmacokinetic profile 61
The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A 61
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 60
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 58
Contribution of asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms to full-length FVIII concentrate pharmacokinetics 58
Translation termination codons in protein synthesis and disease 57
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 57
null 56
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 56
Favourable recombinant factor IX pharmacokinetics outcomes in severe hemophilia B patients with FIX activation site mutations 56
Next generation factor VIIa with enhanced half-life 55
An engineered factor X variant as a novel by-passing agent for hemophilia 53
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 53
The asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms influence several parameters of full-length FVIII concentrate pharmacokinetics 50
Associate Editor per la rivista Frontiers in Pediatrics - sezione Genetic Disorders 50
Academic Editor per la rivista PLoS One 49
Genotype and PK Hemophilia B International Study (GePKHIS) - A progress Report 48
Improved intracellular processing of protein variants as a personalised therapeutic approach for haemophilia 47
Design of a novel factor IX variant with enhanced procoagulant activity and half-life 47
A factor X variant with engineered activation peptide as innovative by-passing agent for haemophilia 46
null 45
The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones 45
null 44
Recombinant Expression of F9 Nonsense Mutations and Fix Pharmacokinetics in Hemophilia B 44
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 44
Exploring base editing for the correction of nonsense mutations in hemophilia B 43
Totale 9.607
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 378
Totale 59.831
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020209 0 0 0 0 0 0 0 0 0 125 55 29
2020/20211.400 64 55 53 92 61 100 255 176 82 198 179 85
2021/20221.181 170 139 37 36 82 72 49 48 35 84 74 355
2022/20231.242 132 144 50 174 179 158 77 79 135 11 58 45
2023/2024856 63 67 44 32 54 156 41 62 29 33 44 231
2024/20252.288 102 78 302 108 394 371 78 90 523 242 0 0
Totale 10.427